DE60036282D1 - Nicht fermentiertes gelanteil aus samenhülsen von psyllium - Google Patents

Nicht fermentiertes gelanteil aus samenhülsen von psyllium

Info

Publication number
DE60036282D1
DE60036282D1 DE60036282T DE60036282T DE60036282D1 DE 60036282 D1 DE60036282 D1 DE 60036282D1 DE 60036282 T DE60036282 T DE 60036282T DE 60036282 T DE60036282 T DE 60036282T DE 60036282 D1 DE60036282 D1 DE 60036282D1
Authority
DE
Germany
Prior art keywords
fermented grain
gel
psyllium seeds
psyllium
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60036282T
Other languages
English (en)
Other versions
DE60036282T2 (de
Inventor
Judith A Marlett
Milton H Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of DE60036282D1 publication Critical patent/DE60036282D1/de
Publication of DE60036282T2 publication Critical patent/DE60036282T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Steroid Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60036282T 1999-06-09 2000-06-08 Nicht fermentiertes gelanteil aus samenhülsen von psyllium Expired - Fee Related DE60036282T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/328,611 US6287609B1 (en) 1999-06-09 1999-06-09 Unfermented gel fraction from psyllium seed husks
US328611 1999-06-09
PCT/US2000/015693 WO2000074689A1 (en) 1999-06-09 2000-06-08 Unfermented gel fraction from psyllium seed husks

Publications (2)

Publication Number Publication Date
DE60036282D1 true DE60036282D1 (de) 2007-10-18
DE60036282T2 DE60036282T2 (de) 2008-06-05

Family

ID=23281664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036282T Expired - Fee Related DE60036282T2 (de) 1999-06-09 2000-06-08 Nicht fermentiertes gelanteil aus samenhülsen von psyllium

Country Status (12)

Country Link
US (2) US6287609B1 (de)
EP (1) EP1189621B1 (de)
JP (2) JP4034564B2 (de)
CN (2) CN100360136C (de)
AT (1) ATE372121T1 (de)
AU (1) AU773580B2 (de)
CA (1) CA2376326C (de)
DE (1) DE60036282T2 (de)
HK (1) HK1044718B (de)
MX (1) MXPA01012581A (de)
RU (2) RU2261102C2 (de)
WO (1) WO2000074689A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287609B1 (en) 1999-06-09 2001-09-11 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks
US6946152B1 (en) 1999-06-09 2005-09-20 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks
DE60136091D1 (de) * 2000-10-13 2008-11-20 E Z Em Inc Ernährungssystem, formulierung, set und methode zur verwendung bei der vorbereitung einer person für eine bestimmte tätigkeit
EG26979A (en) * 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) * 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
CA2459449C (en) 2001-09-08 2011-02-01 Astrazeneca Ab Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
US7195789B2 (en) * 2002-03-07 2007-03-27 Board Of Trustees Of Michigan State University Non-fiber extract of psyllium with anti-tumorigenic effects and method for identifying the same
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US9980988B2 (en) 2002-03-13 2018-05-29 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
JP2003278418A (ja) * 2002-03-22 2003-10-02 Denso Corp 車載無線機装置
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
US7014862B2 (en) * 2002-05-20 2006-03-21 The Procter & Gamble Company Chewable compositions containing a gel-forming extract of psyllium
US20030215534A1 (en) * 2002-05-20 2003-11-20 The Procter & Gamble Company Extraction of unmilled psyllium
US20050042307A1 (en) * 2002-05-21 2005-02-24 Marlett Judith A. Gel-forming polysaccharide from psyllium seed husks
GB0213669D0 (en) * 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0216321D0 (en) * 2002-07-13 2002-08-21 Astrazeneca Ab Therapeutic treatment
US6982254B2 (en) * 2003-02-18 2006-01-03 The Procter & Gamble Company Compositions comprising a plurality of particles or agglomerates having a defined particle size
US20040161471A1 (en) * 2003-02-18 2004-08-19 Cimiluca Paul Alfred Compositions comprising a plurality of particles or agglomerates having a defined particle size
US7098193B2 (en) * 2003-02-18 2006-08-29 The Procter & Gamble Company Compositions comprising a defined polysaccharide component
US7026303B2 (en) * 2003-02-18 2006-04-11 The Procter & Gamble Company Compositions comprising a polysaccharide component and one or more coating layers
GB0304194D0 (en) * 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
AU2008202120B2 (en) * 2003-04-05 2009-12-17 Albireo Ab Use of an IBAT inhibitor for the treatment of prophylaxis of constipation
US20050250734A1 (en) * 2003-11-07 2005-11-10 The Procter & Gamble Company Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels
US7106595B2 (en) * 2004-09-15 2006-09-12 International Business Machines Corporation Apparatus including a thermal bus on a circuit board for cooling components on a daughter card releasably attached to the circuit board
US20060165824A1 (en) * 2005-01-26 2006-07-27 The Procter & Gamble Company Compositions, kits, and methods for enhancing gastrointestinal health
US9420807B2 (en) 2007-04-02 2016-08-23 Purina Animal Nutrition Llc Method of feeding young monogastric mammals and composition fed to young monogastric mammals
US20080293670A1 (en) * 2007-05-23 2008-11-27 Agricultural Research Institute Edible tremella polysaccharide for prevention and/or improvement of intestinal disorder
JP5390091B2 (ja) * 2007-12-05 2014-01-15 矢崎総業株式会社 コネクタ
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2009334511C1 (en) 2008-12-31 2016-08-18 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US20100278949A1 (en) * 2009-05-01 2010-11-04 Jeffery Dale Scott Pre-procedure meal regimen
WO2012064266A1 (en) 2010-11-04 2012-05-18 Albireo Ab Ibat inhibitors for the treatment of liver diseases
RU2015107019A (ru) 2012-08-21 2016-10-10 Эрделикс Инк. Соединения и способы для ингибирования nhe-опосредованного антипорта в лечении расстройств, ассоциированных с задержкой жидкости или солевой перегрузкой и заболеваний желудочно-кишечного тракта
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
RU2675364C2 (ru) 2013-04-12 2018-12-19 Арделикс, Инк Nhe3-связывающие соединения и способы ингибирования транспорта фосфатов
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
KR102560954B1 (ko) 2014-06-25 2023-07-31 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
EP3012252A1 (de) 2014-10-24 2016-04-27 Ferring BV Kristalline Form von elobixibat
JP6698286B2 (ja) * 2015-07-06 2020-05-27 シキボウ株式会社 サイリウムシードガムの製造方法及びサイリウムシードガム
US10226063B2 (en) 2015-10-01 2019-03-12 The United States Of America As Represented By The Secretary Of Agriculture Methods of decreasing the viscosity of a dietary fiber
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
EP3565811A1 (de) 2017-01-09 2019-11-13 Ardelyx, Inc. Inhibitoren des nhe-vermittelten antiports
CN110267944B (zh) 2017-01-09 2024-03-08 阿德利克斯股份有限公司 可用于治疗胃肠道病症的化合物
EP3664781A1 (de) 2017-08-09 2020-06-17 Albireo AB Cholestyramingranulate, orale cholestyraminformulierungen und ihre verwendung
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
KR20210024033A (ko) 2018-06-20 2021-03-04 알비레오 에이비 오데빅시바트의 약학 제제
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
AU2020218908B2 (en) 2019-02-06 2025-01-23 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CA3158184A1 (en) 2019-12-04 2021-08-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
DK4069360T3 (da) 2019-12-04 2024-02-26 Albireo Ab Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
CA3186857A1 (en) 2020-08-03 2022-02-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
CA3196488A1 (en) 2020-11-12 2022-05-19 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
JP2024500309A (ja) 2020-12-04 2024-01-09 アルビレオ エービー ベンゾチア（ジ）アゼピン化合物および胆汁酸モジュレータとしてのその使用
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
CN114343099B (zh) * 2022-01-11 2024-03-26 山东中大药业有限公司 一种l-阿拉伯糖膳食纤维固体饮料及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008771C1 (ru) * 1986-07-25 1994-03-15 Арко Кемикал Компани Низкокалорийный пищевой продукт
MX168010B (es) * 1987-01-06 1993-04-28 Felipe Salete Procedimiento mejorado para la obtencion de mucilago de plantogo psyllium de alta pureza
NL9001980A (nl) * 1990-09-07 1992-04-01 Pharmalett Int Bv Toepassing van polysacchariden in preparaten voor wondbehandeling.
US5248502A (en) * 1991-11-08 1993-09-28 Kellogg Company Method for decreasing the allergenicity of psyllium seed husk by alkaline treatment
US5234916A (en) * 1992-06-12 1993-08-10 The Proctor & Gamble Company Psyllium drink mix compositions
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
RU2112525C1 (ru) * 1995-07-20 1998-06-10 Институт хирургии Восточно-сибирского научного центра СО РАМН Средство для коррекции гиперлипидемии
US6287609B1 (en) 1999-06-09 2001-09-11 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks

Also Published As

Publication number Publication date
US6287609B1 (en) 2001-09-11
CN101219165A (zh) 2008-07-16
AU773580B2 (en) 2004-05-27
DE60036282T2 (de) 2008-06-05
WO2000074689A1 (en) 2000-12-14
RU2314114C2 (ru) 2008-01-10
CN100360136C (zh) 2008-01-09
MXPA01012581A (es) 2002-04-10
CA2376326C (en) 2011-03-15
RU2005102049A (ru) 2006-07-10
CN1365283A (zh) 2002-08-21
AU5599400A (en) 2000-12-28
CA2376326A1 (en) 2000-12-14
RU2261102C2 (ru) 2005-09-27
EP1189621A4 (de) 2004-05-26
EP1189621B1 (de) 2007-09-05
JP4034564B2 (ja) 2008-01-16
HK1044718A1 (en) 2002-11-01
JP2003505436A (ja) 2003-02-12
WO2000074689A8 (en) 2001-06-21
HK1044718B (en) 2008-04-25
US20020142054A1 (en) 2002-10-03
US6676979B2 (en) 2004-01-13
JP2008013575A (ja) 2008-01-24
ATE372121T1 (de) 2007-09-15
EP1189621A1 (de) 2002-03-27

Similar Documents

Publication Publication Date Title
DE60036282D1 (de) Nicht fermentiertes gelanteil aus samenhülsen von psyllium
ATE491436T1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ATE202779T1 (de) Fungizide trifluorophenyl-triazolopyrimidine
YU21401A (sh) Tetrahidropiridoetri
MX336500B (es) Insecticida para uso agricola u horticola y metodo para su uso.
WO2001021766A3 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
IT1278028B1 (it) Macchina agricola combinata che compie, in un solo passaggio l'intera gamma di operazioni per la seminagione.
CR7864A (es) Piridodiacinas como fungicidas de plantas
ATE375359T1 (de) Aminosterolderivate und ihre verwendungen
DK1175433T3 (da) Androgenglycosider og androgen aktivitet deraf
EP1808200A3 (de) Krebsimmuntherapie
DE59610222D1 (de) Sägerät, insbesondere für Mulchsaat
DE50112383D1 (de) Wirkstoffkombinationen
PT1244643E (pt) Inibidores da triptase
PT1244614E (pt) Inibidores de triptase
EP1574507A3 (de) Furo- und Pyrano-Naphthochinone und ihre Verwendung gegen Krebs
ID27733A (id) Metoksiminofenilasetamida
AU2002220713A1 (en) Fungicidal agent combinations
ATE242224T1 (de) Fungizide aza-heterocycloalkene
AU2202301A (en) Cd45 inhibitors
MD1204G2 (ro) Biozidă (25R)-spirost-5-en-3{beta}, 27-diol-27-O-(3-hidroxi-3metilglutaroil) ce posedă proprietăţi fungicide
DK0478837T3 (da) Lactulosepræparat og fremgangsmåde til fremstilling deraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee